Related Experiment Video
Updated: Oct 8, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
The sustainability and environmental impact of virtual care for inflammatory bowel disease: a population-based
Luke J Nguyen1,2, Vivian Huang1,3, Peter Habashi1
1Mount Sinai Centre for Inflammatory Bowel Disease, Toronto, Ontario, Canada.
Background:
The COVID-19 pandemic prompted rapid expansion of virtual specialist care, yet its sustainability and environmental implications remain unclear. We evaluated temporal trends in virtual inflammatory bowel disease (IBD) care and quantified associated reductions in travel-related carbon emissions.
Methods:
We conducted a population-based cohort study of individuals with IBD in Ontario, using linked ICES administrative data. Individuals with established IBD as of April 1, 2020, were followed through March 31, 2025. Outcomes included quarterly rates of virtual IBD specialist visits per 100 IBD capita, the proportion delivered virtually, and estimated carbon emissions avoided from reduced travel. Logistic regression identified predictors of ongoing virtual care.
Results:
Among 98 099 individuals with IBD, 95% of specialist encounters among 62 265 patients with any visit were virtual during the first pandemic fiscal year. Virtual visit rates declined after 2021 and stabilized at approximately one-third of encounters by 2023-2025, while total ambulatory rates were modestly lower than pre-pandemic baseline. Of patients with a virtual visit in 2020-2021, 28% had one in 2023-2024. Older age, lower comorbidity, and residence in low-access regions were associated with reduced odds of continued virtual care. In the first pandemic year, virtual care was estimated to avoid 1268 tonnes of CO2 emissions, equivalent to the annual emissions of 275 passenger cars.
Conclusions:
Virtual IBD specialist care was associated with substantial reductions in estimated travel-related carbon emissions, which diminished as care returned to in-person delivery. Sustainable hybrid care models may preserve environmental benefits while maintaining specialist access.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...